Abstract
Out of a panel of seven monoclonal antibodies with affinity for human lymphoud cells, three were shown to prevent cytotoxic T cell activity, whereas none affected natural killer cell activity when applied without complement. Anti-OKT3 and anti-Leu-2a, with affinity for all T cells and the cytotoxic/suppressive subset, respectively, were both shown to inhibit T killing by their interaction with the effector cell. For anti-OKT3, the inhibition remained after free antibody was washed away. Anti-Leu-2a, in contrast, induced a rapidly reversible inhibition. Using a single cell assay, anti-OKT3 was shown to reduce the lytic ability without affecting target cell binding, whereas anti-Leu-2a prevented the effectors from binding target cells.
Cite
CITATION STYLE
Landegren, U., Ramstedt, U., Axberg, I., Ullberg, M., Jondal, M., & Wigzell, H. (1982). Selective inhibition of human T cell cytotoxicity at levels of target recognition of initiation of lysis by monoclonal OKT3 and Leu-2A antibodies. Journal of Experimental Medicine, 155(5), 1579–1584. https://doi.org/10.1084/jem.155.5.1579
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.